Cervical cancer risk factors and feasibility of visual inspection with acetic acid screening in Sudan

International Journal of Women's Health

Volumn 3, Issue 1, 2011, Pages 117-122

  Ibrahim, Ahmed ^a   Rasch, Vibeke ^b   Pukkala, Eero ^c   Aro, Arja R ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c Institute for Statistical and Epidemiological Cancer Research   (Finland)

Author keywords

Acetic acid; Cervical cancer; Feasibility; Screening; Visual inspection

Indexed keywords

ACETIC ACID;

ADULT; AGE; ARTICLE; ATTITUDE TO HEALTH; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; COLPOSCOPY; CONTRACEPTION; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; EPISIOTOMY; FEASIBILITY STUDY; FEMALE; FEMALE GENITAL MUTILATION; GENITAL INJURY; HIGH RISK POPULATION; HUMAN; LACERATION; PARITY; PILOT STUDY; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; SCREENING TEST; SEXUALITY; SMOKING; SUDAN; UTERINE CERVIX CANCER; VAGINAL DELIVERY; VISUAL INSPECTION WITH ACETIC ACID SCREENING;

EID: 79958045240     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/IJWH.S14189     Document Type: Article

References (44)

1. Carr KC, Sellors JW. Cervical cancer screening in low resource settings using visual inspection with acetic acid. J Midwifery Womens Health. 2004; 49(4): 329-337.
2. Castellsagué X, Bosch FX, Muñoz N, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med. 2002; 346(15): 1105-1112.
3. Castellsagué X, Bosch FX, Muñoz N. The male role in cervical cancer. Salud Publica Mex. 2003; 45 Suppl 3: S345-S353.
4. Biswas LN, Manna B, Maiti PK, Sengupta S. Sexual risk factors for cervical cancer among rural Indian women: a case-control study. Int J Epidemiol. 1997; 26(3): 491-495.
5. Muñoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol. 2000; 19: 1-5.
6. Almonte M, Albero G, Molano M, et al. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine. 2008; 26 Suppl 11: L16-L36.
7. Giuliano AR, Sedjo RL, Roe DJ, et al. Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control. 2002: 13(9): 839-846.
8. Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003; 105: 687-691.
9. Zhang J, Thomas A, Leybovich E. Vaginal douching and adverse health effects: a meta-analysis. Am J Public Health. 1997; 87: 1207-1211.
10. Auvert B, Sobngwi-Tambekou J, Cutler E, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. J Infect Dis. 2009; 199(1): 14-19.
11. Brinton L, Reeves W, Brenes M, et al. Parity as a risk factor for cervical cancer. Am J Epidemiol. 1989; 130(3): 486-496.
12. Rabelo-Santos SH, Zeferino L, Villa LL, et al. Human papillomavirus prevalence among women with cervical intraepithelial neoplasia III and invasive cervical cancer from Goiânia, Brazil. Memórias do Instituto Oswaldo Cruz. 2003; 98: 181-184.
13. Schiff M, Miller J, Masuk M, et al. Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women. Int J Epidemiol. 2000; 29: 983-990.
14. Kanato M, Saranrittichai K. Early experience of sexual intercourse: a risk factor for cervical cancer requiring specific intervention for teenagers. Asian Pac J Cancer Prev. 2006; 7(1): 151-153.
15. Duncan ME, Pelzer A, Tibaux G, Mehari L. Is cervical cancer in Ethiopian women the result of a sexually transmitted disease? Int Surg. 1993; 78(2): 134-140.
16. Shields TS, Brinton LA, Burk RD, et al. A case-control study of risk factors for invasive cervical cancer among US women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev. 2004; 13(10): 1574-1582.
17. The New York Times Company. Cervical cancer. http://adam.about.com/reports/000046_2.htm. Accessed February 3, 2011.
18. Celentano D, Klassen A, Weisman C, Rosenshein N. The role of contraceptive use in cervical cancer: The Maryland Cervical Cancer Case-Control Study. Am J Epidemiol. 1987; 126: 592-604.
19. Menczer J. The low incidence of cervical cancer in Jewish women. Isr Med Assoc J. 2003; 5(2): 120-123.
20. Blumenthal PD, Gaffikin L, Deganus S, et al. Cervical cancer prevention: safety, acceptability and feasibility of single-visit approach in Accra, Ghana. Am J Obstet Gynecol. 2007; 196: 407-409.
21. Sankaranarayanan R, Ramani S, Wesley. A Practical Manual on Visual Screening for Cervical Neoplasia. Lyon, France: IARC; 2003.
22. Wright TC Jr. Chapter 10: cervical cancer screening using visualization techniques. J Natl Cancer Inst. 2003; 31: 66-71.
23. Wright TC Jr, Menton M, Myrtle JF, et al. Visualization techniques (colposcopy, direct visual inspection, and spectroscopic and other visual methods). Summary of Task Force 7. Acta Cytol. 2002; 46(5): 793-800.
24. Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer. 2008; 123(1): 153-160.
25. Ogunbowale T, Lawoyin TO. Cervical cancer risk factors and predictors of cervical dysplasia among women in south-west Nigeria. Aust J Rural Health. 2008; 16(6): 338-342.
26. Soler ME, Blumenthal PD, Gaffikin L, et al. Visual inspection with acetic acid for cervical cancer screening: test qualities in a primary-care setting. Lancet. 1999; 353: 869-873.
27. Blumenthal PD, Gaffikin L, Deganus S, et al. Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am J Obstet Gynecol. 2007; 196: 407-409.
28. Bhatla N, Gulati A, Mathur SR, et al. Evaluation of cervical screening in rural North India. Int J Gynaecol Obstet. 2009; 105(2): 145-149.
29. Sarian LO, Derchain SF, Naud P, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study. J Med Screen. 2005; 12(3): 142-149.
30. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost effectiveness of cervical cancer screening in five developing countries. N Engl J Med. 2005; 353: 2158-2168.
31. Gaffikin L, Lauterbach M, Emerson M. Safety, acceptability, and feasibility of a single visit approach to cervical cancer prevention: results from demonstration project in rural Thailand. http://www.jhpiego.org/scripts/pubs/product_detail.asp?product_id=572. Accessed February 3, 2011.
32. Neumann G, Rasmussen KL, Petersen LK. Cervical adenosquamous carcinoma: tumor implantation in an episiotomy scar. Obstet Gynecol. 2007; 110(2 Pt 2): 467-469.
33. Baloglu A, Uysal D, Aslan N, Yigit S. Advanced stage of cervical carcinoma undiagnosed during antenatal period in term pregnancy and concomitant metastasis on episiotomy scar during delivery: a case report and review of the literature. Int J Gynecol Cancer. 2007; 17(5): 1155-1159.
34. Bader AA, Bjelic-Radisic V, Tamussino KF, et al. Recurrence in a Schuchardt incision after Schauta-Amreich radical vaginal hysterectomy for cervical cancer. Int J Gynecol Cancer. 2006; 16(3): 1479-1481.
35. Cliby WA, Dodson MK, Podratz KC. Cervical cancer complicated by pregnancy: episiotomy site recurrences following vaginal delivery. Obstet Gynecol. 1994; 84(2): 179-182.
36. Khalil AM, Khatib RA, Mufarrij AA, et al. Squamous cell carcinoma of the cervix implanting in the episiotomy site. Gynecol Oncol. 1993; 51(3): 408-410.
37. Gordon AN, Jensen R, Jones HW 3rd. Squamous carcinoma of the cervix complicating pregnancy: recurrence in episiotomy after vaginal delivery. Obstet Gynecol. 1989; 73(5 Pt 2): 850-852.
38. Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002; 359: 1093-1101.
39. Li N, Dai M. Relationship between multiple infections of human papillomavirus and cervical neoplasia among Chinese women in urban areas. Zhonghua Yu Fang Yi Xue Za Zhi. 2010 May; 44(5): 423-6.
40. Brady M. Female genital mutilation: complications and risk of HIV transmission. AIDS Patient Care STDs. 1999; 13(12): 709-716.
41. Punyaratabandhu P, Supanvanich S, Tirapat C, Podhipak A. Epidemiologic study of risk factors in cancer of the cervix uteri in Thai women. J Med Assoc Thai. 1982; 65(5): 231-239.
42. Goldman NA, Goldberg GL. Late recurrence of squamous cell cervical cancer in an episiotomy site after vaginal delivery. Obstet Gynecol. 2003; 101(5 Pt 2): 1127-1129.
43. Cliby WA, Dodson MK, Podratz KC. Cervical cancer complicated by pregnancy: episiotomy site recurrences following vaginal delivery. Obstet Gynecol. 1994; 84(2): 179-182.
44. Baloglu A, Uysal D, Aslan N, Yigit S. Advanced stage of cervical carcinoma undiagnosed during antenatal period in term pregnancy and concomitant metastasis on episiotomy scar during delivery: a case report and review of the literature. Int J Gynecol Cancer. 2007; 17(5): 1155-1159.